This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Has America really drunk its fill of these 5 beverage stocks?

James Dennin, Kapitall: Comsumption of Coke and other soft-drinks is sagging. What could the future hold for these 5 beverage stocks? 

Coca Cola (KO) announced its earnings this week, which revealed more or less exactly what one would have expected: An increasingly health-savvy country is drinking slightly less Coke.  However, the consumer giant made up for this by selling more of everything else, particularly bottled water. 

Read more from Kapitall: Where to find stocks that like higher interest rates (hint: finance)​

Americans, and the rest of the world, are changing their drinking habits.  Not all of it is making us healthier, though.

A big part of the drop in soda sales in the US has been attributed to the rise of energy and sports drinks like Monster (MNST) or Gatorade (PEP). The market as a whole for energy drinks has grown 5000% in the last 15 years. 

It makes sense that Coca-Cola and Pepsi–originally marketed as medicinal beverages for their eye-opening dose of caffeine–would see the biggest downside as the trend plays out. 

We're also drinking a lot more bourbon and whiskey. There's been a number of noteworthy acquisitions in the spirits industry, most notably Beam (BEAM)'s acquisition by the Japanese spirits-maker Suntori. They were likely motivated by the nearly 20% surge in the market for bourbon outside of the US. 

The activity has a number of important takeaways. For one, it shows the increasing importance of an international foothold for beverage makers as taste varies wildly from country to country. India drinks almost half the world's whiskey, for instance. And the average Latin American drinks almost twice as much Coke as the average European. 

It also affirms skepticism toward the efforts of health advocates like Michael Bloomberg who have made a target of sugary drinks.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,596.35 -350.33 -1.95%
S&P 500 2,057.64 -43.85 -2.09%
NASDAQ 4,958.4680 -122.0370 -2.40%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs